Use of pembrolizumab provided long-term benefits in patients with metastatic melanoma, 10-year look shows
A new 10-year analysis led by Igor Puzanov, MD, MSci, FACP, Director of Early Phase…
Browsing: MEK inhibitor
One-two punch drug combination offers hope for pancreatic cancer therapy
Scientists at Sanford Burnham Prebys Medical Discovery Institute, USA, have identified a combination of two…